Investors & Media

Transformative science, targeted medicines

Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Filing date Form Description View
SCHEDULE 13G SCHEDULE 13G - Description View HTML
SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
4 Statement of changes in beneficial ownership of securities View HTML
4 Statement of changes in beneficial ownership of securities View HTML
144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing View HTML
8-K Report of unscheduled material events or corporate event View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-Q Quarterly report which provides a continuing view of a company's financial position View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
DEFA14A Additional proxy soliciting materials - definitive View HTML
ARS An annual report to security holders View HTML

Pagination